Zydus Lifesciences Q2 profit drops 26.6% as costs rise
In short
Zydus Lifesciences said its net profit fell 26.6% to Rs 925.5 crore in the September quarter. Revenue rose to Rs 7,909.6 crore, but expenses jumped to Rs 6,806.6 crore.
The higher costs weighed on earnings even though sales increased. The report does not say what caused the expense jump.
What the reporting says
Zydus Lifesciences reported a 26.6% fall in consolidated net profit to Rs 925.5 crore for the September quarter, according to a regulatory filing. The company said revenue from operations rose to Rs 7,909.6 crore from Rs 6,123.2 crore a year earlier, but total expenses climbed to Rs 6,806.6 crore from Rs 4,509 crore. The immediate issue is higher costs; the reporting does not say what drove the expense surge.
Why it matters
Zydus Lifesciences reported lower quarterly profit even as revenue increased, with consolidated net profit falling to Rs 925.5 crore from Rs 1,260.9 crore in the same quarter a year earlier. The filing said revenue from operations rose to Rs 7,909.6 crore, but total expenses increased sharply to Rs 6,806.6 crore. The report points to cost pressure, but it does not specify the expense drivers.